[
  {
    "title": "Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?",
    "published": 1742570262
  },
  {
    "title": "Axsome (AXSM) Down 0.8% Since Last Earnings Report: Can It Rebound?",
    "published": 1742484626
  },
  {
    "title": "Health Canada approves Biogen\u2019s Skyclarys for Friedreich\u2019s ataxia",
    "published": 1742297727
  },
  {
    "title": "BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant",
    "published": 1741795920
  },
  {
    "title": "Biogen begins dosing in trial of felzartamab for kidney transplant patients with AMR",
    "published": 1741780047
  },
  {
    "title": "New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer\u2019s approach",
    "published": 1741072317
  }
]